Kathryn Schuff, MD

• Degrees:
  MD: University of New Mexico, Albuquerque, 1991
• Residency:
  Oregon Health & Science University, Portland
• Fellowship:
  Endocrinology-Oregon Health & Science University, Portland

• Biosketch:
  Dr. Schuff has clinical and research interests in pituitary and thyroid neoplasms and hormone regulation. She has conducted clinical research projects designed to improve diagnostic procedures as well as treatment modalities for patients with pituitary tumors including Cushing`s syndrome, pituitary hormone deficiencies and thyroid cancer. She codirects the Thyroid Tumor Clinic, a multidisciplinary clinic staffed by endocrinologists and otolaryngologists with close interaction with OHSU`s head and neck radiologist and nuclear medicine staff to provide comprehensive, coordinated care for patients with thyroid and parathyroid disease. She also practices in the General Endocrinology clinic seeing patients with thyroid, adrenal, reproductive endocrine and pituitary problems.
  
• Publications:

  Schuff KG, Nusser KD, Kumar TR, Low MJ. Gonadotroph-specific expression of the human FSHß gene requires both proximal 5' promoter and distal 3' flanking sequences. Manuscript in revision for submission to Endocrinology.

  Schuff KG, Hentges ST, Kelly MA, Binart N, Kelly PA, Asa SL, Low MJ. Lack of prolactin receptor signaling results in lactotroph proliferation and prolactinomas by dopamine-dependent and independent mechanisms. J Clin Invest 2002;110:973-81.

  Graham (Schuff) KE, Nusser KD, Low MJ. LbT2 gonadotroph cells secrete FSH in response to activin A. J Endocrinol 1999;162:R1-R5.

  Graham (Schuff) KE, Samuels MH, Cook DM, Nesbit GM, O'Neill OR, Barnwell SN, Loriaux, DL. Cavernous sinus sampling is highly accurate in distinguishing Cushing's disease from the ectopic adrenocorticotropin syndrome and in predicting intrapituitary tumor location. J Clin Endocr Metab 1999;84:1602-10.

  Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Graham (Schuff) KE, et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999; 84:3877-85.
  

• All Publications